50765-11-2

Usage

Uses

Used in Organic Synthesis:
5-HYDROXY-2-IODOBENZALDEHYDE is used as a precursor in organic synthesis for the production of a range of chemical compounds. Its unique structure allows it to be a key component in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-HYDROXY-2-IODOBENZALDEHYDE is utilized as a starting material for the development of biologically active compounds. Its potential to contribute to the creation of new drugs makes it a valuable asset in medicinal chemistry.
Used in Material Science for Electronic Devices:
5-HYDROXY-2-IODOBENZALDEHYDE has been studied for its potential applications in material science, particularly for the development of materials used in electronic devices. Its properties may contribute to advancements in this field.
Used in Other Industrial Applications:
Beyond the realms of organic synthesis and pharmaceuticals, 5-HYDROXY-2-IODOBENZALDEHYDE also finds use in various other industrial applications where its chemical properties are beneficial.
It is crucial to handle 5-HYDROXY-2-IODOBENZALDEHYDE with care due to its potential health hazards if not used properly, emphasizing the need for safety measures during its manipulation and application.

InChI:InChI=1/C7H5IO2/c8-7-2-1-6(10)3-5(7)4-9/h1-4,10H

Upstream product

• 100-83-4 meta-hydroxybenzaldehyde 
• 7732-18-5 water 
• 7553-56-2 iodine 
• 127-09-3 sodium acetate 
• 77287-58-2 2-iodo-5-methoxybenzaldehyde 

Downstream Products

• 57772-57-3 5-hydroxy-2-iodo-benzoic acid 
• 91719-57-2 3-allyl-5-(5-hydroxy-2-iodo-benzylidene)-2-thioxo-thiazolidin-4-one 
• 91426-81-2 3-ethyl-5-(5-hydroxy-2-iodo-benzylidene)-2-thioxo-thiazolidin-4-one 
• 50765-12-3 5-(benzyloxy)-2-iodobenzaldehyde 
• 929087-90-1 3-[2-(2-{2-[2-(3-formyl-4-iodo-phenoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-propionic acid tert-butyl ester 
• 929087-92-3 3-{2-[2-(2-{2-[2-formyl-2'-(isoxazol-5-ylsulfamoyl)-biphenyl-4-yloxy]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-N-(4-{2-[2-(2-methyl-[1,3]dioxolan-2-ylmethyl)-[1,3]dioxolan-2-yl]-ethyl}-phenyl)-propionamide 
• 929087-81-0 N-[4-(2-{2-[2-(2-{2-[4-(3,5-dioxo-hexyl)-phenylcarbamoyl]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-ethoxy)-2'-(isoxazol-5-ylsulfamoyl)-biphenyl-2-ylmethyl]-3,3,N-trimethyl-butyramide 
• 929087-93-4 N-(2'-(isoxazol-5-ylsulfamoyl)-4-{2-[2-(2-{2-[2-(4-{2-[2-(2-methyl-[1,3]dioxolan-2-ylmethyl)-[1,3]dioxolan-2-yl]-ethyl}-phenylcarbamoyl)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-biphenyl-2-ylmethyl)-3,3,N-trimethyl-butyramide 
• 50765-13-4 (5-(benzyloxy)-2-iodophenyl)methanol 
• 50765-14-5 5-Benzyloxy-2-iodbenzylchlorid 
• 42061-75-6 2-(5-Hydroxy-2-iodphenyl)aethylamin 
• 50765-16-7 2-(5-Benzyloxy-2-iodphenyl)aethylamin 
• 50765-15-6 5-Benzyloxy-2-iodbenzylcyanid 

Relevant academic research and scientific papers

INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE - SYNTHESIS AND USE THEREOF FOR TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA

The present invention relates to new compounds of general formula I, their synthesis, their pharmaceutically acceptable salts, and their use in treatment of T-cell acute lymphoblastic leukemia and lymphoma.

Stereoselective synthesis of a: Podophyllum lignan core by intramolecular reductive nickel-catalysis

A Ni-catalyzed reductive cascade to a diastereocontrolled construction of THN[2,3-c]furan, is developed. The mild reaction conditions led to the tolerance of broad functional groups that can be placed in almost every position of this skeleton with good yields. The conformational control for the observed trans- or cis-fused selectivity during this tandem cyclization-coupling is also proposed.

ALKYNE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

Provided are compounds of formula (Ia) and pharmaceutically acceptable salts thereof, wherein A, B, R 1, R 2, m and n are as defined herein, which are active as inhibitors of S-Nitrosoglutathione reductase (GSNOR). These compounds prevent, inhibit, or suppress the action of GSNOR and are therefore useful in the treatment of GSNOR mediated diseases, disorders, syndromes or conditions such as, e.g., pulmonary hypertension, acute respiratory distress syndrome (ARDS), asthma, bronchospasm, cough, pneumonia, pulmonary fibrosis, interstitial lung diseases, cystic fibrosis and chronic obstructive pulmonary disease (COPD).